These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 26091704)

  • 41. Positron emission tomography (PET) attenuation correction artefacts in PET/CT and PET/MRI.
    Buchbender C; Hartung-Knemeyer V; Forsting M; Antoch G; Heusner TA
    Br J Radiol; 2013 May; 86(1025):20120570. PubMed ID: 23580397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Semiquantitative Assessment of
    Minamimoto R; Xu G; Jamali M; Holley D; Barkhodari A; Zaharchuk G; Iagaru A
    AJR Am J Roentgenol; 2017 Nov; 209(5):1136-1142. PubMed ID: 28777652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of MR-based attenuation correction in spinal cord FDG-PET/MR imaging for neurological studies.
    Brancato V; Borrelli P; Alfano V; Picardi M; Mascalchi M; Nicolai E; Salvatore M; Aiello M
    Med Phys; 2021 Oct; 48(10):5924-5934. PubMed ID: 34369590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System.
    Yang J; Jian Y; Jenkins N; Behr SC; Hope TA; Larson PEZ; Vigneron D; Seo Y
    Radiology; 2017 Jul; 284(1):169-179. PubMed ID: 28234560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
    Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients.
    Ladefoged CN; Law I; Anazodo U; St Lawrence K; Izquierdo-Garcia D; Catana C; Burgos N; Cardoso MJ; Ourselin S; Hutton B; Mérida I; Costes N; Hammers A; Benoit D; Holm S; Juttukonda M; An H; Cabello J; Lukas M; Nekolla S; Ziegler S; Fenchel M; Jakoby B; Casey ME; Benzinger T; Højgaard L; Hansen AE; Andersen FL
    Neuroimage; 2017 Feb; 147():346-359. PubMed ID: 27988322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical issues regarding misclassification by Dixon based PET/MR attenuation correction.
    Kong E; Cho I
    Hell J Nucl Med; 2015; 18(1):42-7. PubMed ID: 25840572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients.
    Cabello J; Lukas M; Förster S; Pyka T; Nekolla SG; Ziegler SI
    J Nucl Med; 2015 Mar; 56(3):423-9. PubMed ID: 25678486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
    Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
    Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Markerless attenuation correction for carotid MRI surface receiver coils in combined PET/MR imaging.
    Eldib M; Bini J; Robson PM; Calcagno C; Faul DD; Tsoumpas C; Fayad ZA
    Phys Med Biol; 2015 Jun; 60(12):4705-17. PubMed ID: 26020273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interpolated average CT for attenuation correction in PET--a simulation study.
    Mok GS; Sun T; Huang TC; Vai MI
    IEEE Trans Biomed Eng; 2013 Jul; 60(7):1927-34. PubMed ID: 23392338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
    Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
    Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
    Visvikis D; Costa DC; Croasdale I; Lonn AH; Bomanji J; Gacinovic S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):344-53. PubMed ID: 12634961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging.
    Blumhagen JO; Braun H; Ladebeck R; Fenchel M; Faul D; Scheffler K; Quick HH
    Med Phys; 2014 Feb; 41(2):022303. PubMed ID: 24506641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET/MR imaging.
    Izquierdo-Garcia D; Sawiak SJ; Knesaurek K; Narula J; Fuster V; Machac J; Fayad ZA
    Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1574-84. PubMed ID: 24652234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.